title: Type III hypersensitivity reaction with the use of interferon-alpha.
authors.forename: M A
authors.initials: MA
authors.lastname: Maurtua
authors.forename: L C
authors.initials: LC
authors.lastname: Moscinski
authors.forename: J
authors.initials: J
authors.lastname: Messina
authors.forename: L
authors.initials: L
authors.lastname: Miller
authors.forename: O F
authors.initials: OF
authors.lastname: Ballester
mesh_terms: D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology* / Q000473:pathology; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000276:immunology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008875:Middle Aged; D011994:Recombinant Proteins; D012867:Skin / Q000276:immunology
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins